Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer
2016 ◽
Vol 158
(2)
◽
pp. 233-241
◽
2016 ◽
Vol 34
(15_suppl)
◽
pp. e23268-e23268
2013 ◽
Vol 134
(1)
◽
pp. 72-80
◽
2019 ◽
Vol 128
(1)
◽
pp. e51
2016 ◽
Vol 17
(2)
◽
pp. 139-153
◽
Keyword(s):
2001 ◽
Vol 37
◽
pp. S262
◽
Keyword(s):